Publication @ Staburo: Treatment of Oropharyngeal Symptoms: A Prospective, Single-Dose, Placebo-Controlled, Randomized Clinical Trial

Publication @ Staburo: Treatment of Oropharyngeal Symptoms: A Prospective, Single-Dose, Placebo-Controlled, Randomized Clinical Trial

Staburo contributed data science expertise to medical device study 

Staburo supported the German pharmaceutical company, Dr. Pfleger Arzneimittel GmbH, Bamberg, during the whole lifecycle of the ‘ipalat® Hydro Med’ study in terms of protocol writing, randomisation, statistical analysis plan writing, statistical programming, report and publication writing. The prospective, single-dose, placebo-controlled, randomized clinical trial investigated whether sucking and chewing the ‘ipalat® Hydro Med’ pastille (class I, CE-certified medical device) containing a specific mixture of four different polysaccharides provides instantaneous relieving effects for acute oropharyngeal symptoms such as sore throat, difficulty swallowing, hoarseness, tickly throat, and dry mouth. Find out more about the study results being published here https://doi.org/10.2147/OAJCT.S331883

Data analysis, clinical biostatistics and more.

Staburo @ PSI Medical Statistics Careers Event 2022

Staburo @ PSI Medical Statistics Careers Event 2022

Staburo @ PSI Medical Statistics Careers Event 2022

Staburo took part in the online Careers Event on 2 March 2022.

The event was aimed at students with an interest in the field of Medical Statistics, for example within pharmaceuticals, healthcare and/or medical research.

Several Staburo colleagues joined the virtual Career fair, where students could book individual meetings, and discuss job opportunities at our company in the areas of Data Science, Biostatistics and Statistical Programming.

Check out more information on the PSI website. We thank the PSI team for organizing this event and are looking forward to joining next year!

Data analysis, clinical biostatistics and more.

Staburo @ APF meeting by International Biometric Society German Region

Staburo @ APF meeting by International Biometric Society German Region

Staburo @ APF meeting

On November 26, Staburo participated in the annual workshop of the APF (working group Pharmaceutical Research) by the International Biometric Society German Region. This year’s workshop (just like the one last year) took place virtually due to Covid-19 and focused on the topic “Breakthrough Therapies”, the agenda can be found: HERE

This year, Staburo was granted the privilege of organising the virtual evening meeting on November 25. In honour of the Munich roots of our company, each participant received a beer package for an online beer-tasting event, organised by Staburo Managing Director Dr. Hannes Buchner. The package contained four different types of beer, each of them brewed in or around Munich and, as a highlight, included the home-brewed “Staburator” beer.

During the workshop, the attendees listened to a talk about EU early access schemes including a Risk/Benefit assessment of early market access. Furthermore, the presentations included a talk regarding potential statistical challenges faced by planning a confirmatory trial for breakthrough therapies. In the end, the topic of early access was revisited, this time focusing on early access in the German HTA-procedure – concluding that it does not make life in German HTA easier.

The presentations were topped off with a detailed discussion of the most interesting aspects.

All participants are looking forward to another successful workshop in 2022, which will hopefully provide the possibility to interact and discuss in person again!

Data analysis, clinical biostatistics and more.

Staburo presents at University of Konstanz about the work life of a biostatistician

Staburo presents at University of Konstanz about the work life of a biostatistician

Staburo presents at lecture series ‚Mathematik im Beruf‘ at University of Konstanz 

Susanne Steinhauser from Staburo GmbH presented the working life of a biostatistician at the ‘Mathematik im Beruf’ series at the University of Konstanz. The series of lectures aim to introduce possible future working fields to students and PhD students of the mathematical faculty. During the presentation and subsequent discussion, the students learned about the different tasks of a biostatistician in a clinical study, a typical workday as well as possibilities of starting a career in this field of work. It was a great pleasure to talk about the topics that we are passionate about and in which we see a very big purpose. We hope that we could spark interest in the students to join us and consider a career in biostatistics! A big thank you goes to University of Konstanz for giving us this opportunity!

Data analysis, clinical biostatistics and more.

Staburo @ R/Pharma 2021 Conference

Staburo @ R/Pharma 2021 Conference

Staburo @ R/Pharma 2021 Conference

Staburo participated in the R/Pharma 2021 Conference hosted by a committee existing of R practitioners from different companies, universities, and the FDA from the 2– 4 November. The conference took place online due to Covid19.

The conference provided an overview of new and upcoming R packages in the development of pharmaceuticals and discussed the challenges and opportunities of using R in the pharma industry. For example, the admiral package developed by Roche and gsk offers a consistent and CDISC compliant way to generate ADaM datasets in R. Furthermore, the GeneTonic package provides a Shiny application that makes it easier to analyze and visualize transcriptome data and results.

In addition to the usual discussions within the presentations there was also time to exchange views on all statistical and pharmaceutical topics throughout the conference. In this context, attention was also drawn to a statistical YouTube channel, which we would like to share with you.

We are looking forward to participating in next year’s conference where we can hopefully meet the speakers and attendees in real life!

Data analysis, clinical biostatistics and more.